創薬サービス市場 – 2030年までの世界予測

出版社 MarketsandMarkets
出版年月 2025年3月

Drug Discovery Services Market – Global Forecast to 2030

創薬サービス市場 – プロセス [ターゲット検証、リードジェネレーション（H2L）、リード最適化]、タイプ (化学、生物学)、治療領域 (腫瘍学、神経学、感染症、CVD)、薬剤タイプ (小分子、生物製剤)、エンドユーザー – 2030年までの世界予測
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User – Global Forecast to 2030

The global drug discovery services market is anticipated to reach USD 27.23 billion in 2030 from USD 16.36 billion in 2025, with a significant CAGR of 10.7%.

世界の創薬サービス市場は、2025年の163.6億米ドルから2030年には272.3億米ドルに達し、年平均成長率10.7%で成長すると予想されています。

The market is growing strongly at a considerable CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives on the rare diseases and orphan drugs. Furthermore, the high costs of in-house drug development have also contributed to this trend.  Industry players are likely to witness healthy growth opportunities due to the technological advancement, new drug discovery techniques, patent expiry, and rising demand for specialized testing services among end users.

製薬会社やバイオ製薬会社の研究開発投資の増加により、市場は相当なCAGRで力強く成長しています。研究開発のパイプラインが拡大するにつれ、希少疾患や希少疾病用医薬品に関する研究イニシアチブに加えて、分析試験のアウトソーシングの要件も高まると見込まれています。さらに、社内での医薬品開発にかかる高コストもこの傾向に寄与しています。業界関係者は、技術の進歩、新薬発見技術、特許の満了、エンドユーザーの間での専門的な試験サービスに対する需要の高まりにより、健全な成長の機会を目の当たりにする可能性があります。

創薬サービス市場 – 2030年までの世界予測
drug-discovery-services-market-Ecosystem

Thermo Fisher Scientific Inc. (US), Labcorp (US), Eurofins Scientific (Germany), Charles River Laboratories (US), WuXi AppTec (China), Pharmaron (China), Evotec (Germany), Syngene International Limited (India), Curia Global, Inc. (US), Aragen Life Sciences Ltd. (India), Jubilant Pharmova Limited (India), Dr. Reddy’s Laboratories Ltd.  (India), Frontage Holdings Corporation (US), GenScript (US), Sygnature Discovery (UK), and Piramal Enterprises Ltd. (India) are some of the key players in the drug discovery services market.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, Increasing demand for outsourcing analytical testing services, Initiatives for research on rare diseases and orphan drugs, High cost of in-house drug development), restraints (Stringent regulations governing drug discovery and animal usages), opportunities (Growth in drugs and biologics market, Rising demand for specialized testing services among end users, Patent Expiry, High growth prospect in emerging markets) and Challenges (Economic uncertainties worldwide) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on upcoming technologies in drug discovery services, research and development activities, and new service launches in the drug discovery services market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the drug discovery services market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players Charles River Laboratories (US), Thermo Fisher Scientific Inc. (US), WuXi AppTec (China), and Pharmaron (China), and Labcorp (US), among others.